Abstract
This study evaluated lactate dehydrogenase (LDH) as a prognostic factor for survival time in terminal cancer patients. We prospectively followed 93 consecutive inpatients with terminal cancer in one general hospital. Cox's proportional hazard model was used to adjust the influence of some clinical and laboratory variables on survival time. For 25 patients, LDH levels at 2 weeks and 1 week before death were compared by paired t test. In multivariate analysis, elevated LDH level (≥313 IU/L) was confirmed as an unfavourable indicator for survival time (hazard ratio = 2.087, p = 0.002). Serum LDH levels were significantly increased as the patients approached death. A combined index comprising LDH levels, C reactive protein levels, uric acid levels, presence of moderate to severe pain, fatigue, hypotension and performance status demonstrated a good stratification value for predicting survival time. Our results showed that serum LDH level can be a useful predictor of survival time of terminally ill cancer patients.
Original language | English |
---|---|
Pages (from-to) | 1051-1059 |
Number of pages | 9 |
Journal | European Journal of Cancer |
Volume | 43 |
Issue number | 6 |
DOIs | |
State | Published - Apr 2007 |
Keywords
- Lactate dehydrogenase
- Palliative care
- Prognostic factor
- Survival time
- Terminal cancer